Titan Pharmaceuticals (de) Operating Income

Titan Pharmaceuticals (de) (TTNP) currently reports a operating income of $-2.4M as of December 2025. That compares with $-4.6M in the prior-year period — up 47.0% year over year. Use the charts on this page to explore Titan Pharmaceuticals (de)'s operating income history and peer comparisons.

Titan Pharmaceuticals (de)'s operating income increased from $-4.6M to $-2.4M — a 47.0% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Titan Pharmaceuticals (de) reported $-2.4M in operating income as of December 2025. That compares with $-4.6M in the prior-year period — up 47.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-2.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Titan Pharmaceuticals (de), and consider following TTNP for alerts when major investors trade the stock.

Titan Pharmaceuticals (de) is classified in the Healthcare sector. On operating income, it currently shows $-2.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TTNP with unrelated industries.